Research ArticleClinical Studies
Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma
ATSUSHI ITO, TOMOHITO TARUKAWA, YUTA SUZUKI, TADASHI SAKAGUCHI, KENTARO ITO, KENTARO FUJIWARA, YOICHI NISHII, OSAMU TAGUCHI, HIROKI YASUI, MOTOSHI TAKAO and OSAMU HATAJI
Anticancer Research November 2023, 43 (11) 5197-5204; DOI: https://doi.org/10.21873/anticanres.16721
ATSUSHI ITO
1Respiratory Center, Department of Thoracic Surgery, Matsusaka Municipal Hospital, Matsusaka, Japan;
2Department of Thoracic and Cardiovascular Surgery, Mie University Graduate School of Medicine, Tsu, Japan;
TOMOHITO TARUKAWA
1Respiratory Center, Department of Thoracic Surgery, Matsusaka Municipal Hospital, Matsusaka, Japan;
YUTA SUZUKI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
TADASHI SAKAGUCHI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
KENTARO ITO
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
KENTARO FUJIWARA
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
YOICHI NISHII
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
OSAMU TAGUCHI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
HIROKI YASUI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan
MOTOSHI TAKAO
2Department of Thoracic and Cardiovascular Surgery, Mie University Graduate School of Medicine, Tsu, Japan;
OSAMU HATAJI
3Respiratory Center, Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Japan

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma
ATSUSHI ITO, TOMOHITO TARUKAWA, YUTA SUZUKI, TADASHI SAKAGUCHI, KENTARO ITO, KENTARO FUJIWARA, YOICHI NISHII, OSAMU TAGUCHI, HIROKI YASUI, MOTOSHI TAKAO, OSAMU HATAJI
Anticancer Research Nov 2023, 43 (11) 5197-5204; DOI: 10.21873/anticanres.16721
Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma
ATSUSHI ITO, TOMOHITO TARUKAWA, YUTA SUZUKI, TADASHI SAKAGUCHI, KENTARO ITO, KENTARO FUJIWARA, YOICHI NISHII, OSAMU TAGUCHI, HIROKI YASUI, MOTOSHI TAKAO, OSAMU HATAJI
Anticancer Research Nov 2023, 43 (11) 5197-5204; DOI: 10.21873/anticanres.16721
Jump to section
Related Articles
- No related articles found.
Cited By...
- Clinicopathological and Molecular Insights into Primary Retroperitoneal Squamous Cell Carcinoma: HPV Association and Discovery of Recurrent PIK3CA E545K Mutation
- MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma
- Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma